Last updated: 2026-09-16 13:20:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Omnicell Inc. (OMCL) operates in the ELECTRONIC COMPUTERS sector and is listed on NASDAQ. The stock is currently priced at $32.65, with a market capitalisation of $1.53B and a P/E ratio of 38.08. Over the past 52 weeks, its price has ranged from $29.06 to $55.00. This page covers its latest market performance, valuation, price trends and company information.
$1.53B | |
$32.66 | |
$187.29 | |
$5.62 | |
$32.63 | |
4.53K | |
745.53K | |
38.08 | |
$55.00 | |
$29.06 | |
-- | |
-- |
Omnicell Inc. (OMCL) is trading at $32.65 in pre-market trading as of 2026-09-16 13:18:00, up 0.06% ($0.02) from the previous close of $32.63
Pre-market trading shows how investors are pricing OMCL before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Omnicell Inc. (OMCL) moved from $34.37 to $32.65, representing a decline of 5.00% ($1.72).
The stock traded between $32.12 and $35.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 566.93 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 13.8%
OMCL is currently trading at $32.65, placing it 13.8% of the way from its 52-week low of $29.06 to its 52-week high of $55.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
| Industry | ELECTRONIC COMPUTERS |
| Employees | 3485 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Omnicell Inc. (OMCL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.